T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis

Experimental and Therapeutic Medicine

Volumn 9, Issue 1, 2015, Pages 250-256

  Wang, Chenggong ^a   Liao, Qiande ^a   Hu, Yihe ^a   Zhong, Da ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Cytokines; Imbalance; Inflammation; T lymphocyte subsets

Indexed keywords

ALPHA GLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 17; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELPER CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH1 TH2 BALANCE; TH17 CELL;

EID: 84919444488     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2046     Document Type: Article

References (36)

1. Calin A, Porta J, Fries JF and Schurman DJ: Clinical history as a screening test for ankylosing spondylitis. JAMA 237: 2613-2614, 1977.
2. Braun J and Sieper J: Ankylosing spondylitis. Lancet 369: 1379-1390, 2007.
3. Gran JT and Skomsvoll JF: The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatology 36: 766-771, 1997.
4. Van der Linden S, Valkenburg HA and Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361-368, 1984.
5. Graham B and Van Peteghem PK: Fractures of the spine in ankylosing spondylitis. Diagnosis, treatment, and complications. Spine (Phila Pa 1976) 14: 803-807, 1989.
6. Braun J, Brandt J, Listing J, et al: Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359: 1187-1193, 2002.
7. Akhtar S, O'Flynn PE, Kelly A and Valentine PM: The management of dysphasia in skeletal hyperostosis. J Laryngol Otol 114: 154-157, 2000.
8. Imhof H and El-Khoury GY: Traumas of the Axial Skeleton. In: Musculoskeletal Diseases. Springer, Milan, pp112-120, 2005.
9. Van der Linden SM, Valkenburg HA, de Jongh BM and Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27: 241-249, 1984.
10. Brown MA, Kennedy LG, MacGregor AJ, et al: Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40: 1823-1828, 1997.
11. Jacobs JC, Berdon WE and Johnston AD: HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J Pediatr 100: 521-528, 1982.
12. Leirisalo-Repo M: Reactive arthritis. Scand J Rheumatol 34: 251-259, 2005.
13. Atagunduz P, Appel H, Kuon W, et al: HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum 52: 892-901, 2005.
14. Braun J, Khan MA and Sieper J: Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response? Ann Rheum Dis 59: 985-994, 2000.
15. Brandt J, Haibel H, Cornely D, et al: Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43: 1346-1352, 2000.
16. Reinherz EL and Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19: 821-827, 1980.
17. Sallusto F, Lenig D, Förster R, Lipp M and Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712, 1999.
18. Lucey DR, Clerici M and Shearer GM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9: 532-562, 1996.
19. Wilke CM, Bishop K, Fox D and Zou W: Deciphering the role of Th17 cells in human disease. Trends Immunol 32: 603-611, 2011.
20. Yen HR, Harris TJ, Wada S, et al: Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol 183: 7161-7168, 2009.
21. Szalay B, Mészáros G, Cseh Á, et al: Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy. Clin Dev Immunol 2012: 808724, 2012.
22. Raffeiner B, Dejaco C, Duftner C, et al: Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis. Arthritis Res Ther 7: R1412-R1420, 2005.
23. Lin Q, Gu JR, Li TW, et al: Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. Chin Med J (Eng) 122: 1784-1789, 2009.
24. Wu Y, Ren M, Yang R, et al: Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther 13: R29, 2011.
25. Kidd P: Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8: 223-246, 2003.
26. Yao S, Hong CC, McCann SE, et al: Combined effects of circulating levels of 25-hydroxyvitamin d and Th1 and th2 cytokines on breast cancer estrogen receptor status. Cancers (Basel) 6: 211-225, 2014.
27. Hou N, Zhang X, Zhao L, et al: A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth. Biochem Biophys Res Commun 439: 471-476, 2013.
28. Gut W, Pancer K, Abramczuk E, et al: RSV respiratory infection in children under 5 y.o. - - dynamics of the immune response Th1/Th2 and IgE. Przegl Epidemiol 67: 17-22, 2013.
29. Vitry MA, De Trez C, Goriely S, et al: Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun 80: 4271-4280, 2012.
30. Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139-145, 2007.
31. Yasukawa S, Dainichi T, Kokuba H, et al: Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes. Eur J Dermatol 19: 69-71, 2009.
32. Bryant C, Suen H, Brown R, et al: Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance. Blood Cancer J 3: e148, 2013.
33. Gaur P, Qadir GA, Upadhyay S, Singh AK, Shukla NK and Das SN. Skewed immunological balance between Th17 (CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in human oral squamous cell carcinoma. Cell Oncol (Dordr) 35: 335-343, 2012.
34. Iwakura Y, Nakae S, Saijo S and Ishigame H: The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 226: 57-79, 2008.
35. Cañete JD, Martínez SE, Farrés J, et al: Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 59: 263-268, 2000.
36. Rudwaleit M, Haibel H, Baraliakos X, et al: The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 60: 717-27, 2009.